Related Experiment Videos
Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging
K Weingarten1, D Barbut, C G Filippi
1Department of Radiology, New York Hospital-Cornell Medical Center, NY 10021.
AJR. American Journal of Roentgenology
|March 1, 1994
Summary
Magnetic resonance imaging (MRI) effectively detects edema in hypertensive encephalopathy. Gradient-echo MRI is crucial for identifying petechial hemorrhages, distinguishing this condition from other white matter diseases.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Hypertensive encephalopathy is a neurological condition characterized by brain dysfunction due to severe hypertension.
- Distinguishing between reversible edema and irreversible infarction in hypertensive encephalopathy can be challenging.
Purpose of the Study:
- To investigate the findings on spin-echo and gradient-echo MRI in patients with hypertensive encephalopathy.
- To assess the utility of different MRI sequences in characterizing brain changes associated with hypertensive encephalopathy.
Main Methods:
- Prospective examination of MRI scans from 36 patients with acute hypertensive encephalopathy (< 72 hours).
- Assessment of brain swelling (short TR images), hyperintensity (long TR images), and hypointensity (long TR and gradient-echo images).
Main Results:
- Supratentorial white matter hyperintensity was common (n=32), indicating edema, infarction, or ischemic disease.
- Characteristic edema was observed in basal ganglia (n=22), brainstem (n=15), and cerebellum (n=11).
- Punctate hypointensities on gradient-echo images were a distinguishing feature, indicative of petechial hemorrhages.
Conclusions:
- MRI is effective in visualizing deep ganglionic and posterior fossa edema, typical of hypertensive encephalopathy.
- Serial MRI studies are needed to differentiate transient edema from permanent infarction.
- Gradient-echo MRI is valuable for detecting petechial hemorrhages, a marker distinguishing hypertensive encephalopathy from other white matter diseases.